MedPath

To determine effect of intravenous magnesium sulphate on spinal anesthesia for Caesarean section in pre eclamptic patients.

Not Applicable
Conditions
Health Condition 1: O149- Unspecified pre-eclampsia
Registration Number
CTRI/2021/08/035418
Lead Sponsor
Department Of Anesthesiology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of preeclampsia undergoing elective caesarean section:

2.Systolic blood pressure 140-160mmHg

3.Diastolic blood pressure >90mm hg

4.Proteinuria <5g within 24 h

5.Body weight 45 to 70 kg

6.Height-145-165cm

7.Patients without headache, dizziness, and dyspnea

Exclusion Criteria

1.Patients not willing to participate in the study.

2. Cases with sepsis, bacteremia or skin infection of local site

3. History of severe hypovolemia, anemia and compromised renal, cardiac or respiratory status

4. Cases with raised intracranial tension

5. History of blood coagulopathies

â?? Patient allergic to drugs used for study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the difference in characterstics of nerve block and duration of analgesia in both groups.Timepoint: Baseline to 24 hour postoperative.
Secondary Outcome Measures
NameTimeMethod
1.To determine the difference in change in hemodynamic variables (Heart Rate; Mean Blood Pressure; Systolic Blood Pressure; Diastolic Blood Pressure). <br/ ><br>2.To compare the proportion of cases with complications. <br/ ><br>Timepoint: Baseline to 24 hour postoperative
© Copyright 2025. All Rights Reserved by MedPath